TURKISH JOURNAL OF ONCOLOGY 1995 , Vol 10 , Num 3
INTERPHERON-ALPHA TREATMENT IN PRIMARY MYELOFIBROSIS
BERKSOY ŞAHİN, SEMRA PAYDAŞ, ERTUĞRUL SEYREK, GÜLFİLİZ GÖNLÜŞEN, İLHAN TUNCER
Çukurova Üniversitesi Tıp Fakültesi Onkoloji BD Primary myelofibrosis which is characterized with splenomegaly, leucoerythroblastic, and poikilocytic peripheral blood smear morphology is a myeloproliferative disorder. It has not been postulated a standard and a curative therapy for the disease in randomized studies up to now. In this report we presented our experience about a patient who received 3x106U IFN-alpha 2b three times per week and about the marked reduction in bone marrow fibrosis in addition to the regression in clinical signs. Keywords :